Washington, D.C. · Nonprofit
INTERNATIONAL CANCER EXPERT CORPS INC
INTERNATIONAL CANCER EXPERT CORPS INC (Washington, D.C.) receives grants from 5 organizations whose IRS filings report $299,552 to it, the largest being MORGAN STANLEY GLOBAL IMPACT FUNDING TRUST INC ($200,000). 3 of them have funded it in more than one year, and 97% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- Revenue FY2024
- $1.5M
- Funders on record
- 5
- Grants received
- $300k
- Net assets
- $2.3M
What International Cancer Expert Corps Inc does
Mission
Icec's mission is to reduce mortality and improve the quality of life for people with cancer in low- and middle-income countries, as well as the indigenous and geographically underserved populations in upper-income countries and regions worldwide through a mentoring network of cancer professionals.
As stated on its FY2024 Form 990.
Programs
Icec twinning programs/mentoring partnershipscancer care building capacity and capability for low- and middle-income countries (lmic) through mentorship and innovative technology there are low-middle-income countries (lmics) where there is almost no access to cancer care leading to unnecessary deaths and immeasurable suffering. What is needed is access to the appropriate expertise built from the local community and treatment with effective technology to ensure sustainable capacity and capability. The international cancer expert corps is addressing the shortage of cancer care through a two-pronged approach of (1) twinning programs and mentorship to build and sustain expertise and (2) innovative "smart" technology to provide radiation therapy and knowledge-assisted treatment. The icec mentorship corps is being built with international partners in resource-rich high-income countries (hics) with experts serving as mentors with twinning partnerships among champions in lmics. While there is a good measure of volunteerism, financial support is needed for the twinning partners to have the time and basic resources for education, training and ongoing active partnership. In 2021, icec…
$52,353 spent$66,708 earned by the program19% of program spendingDeveloping novel medical linear accelerators (linacs) for challenging environments in low- and middle-income countries (lmic) there are low-and middle-income countries (lmics) where there is almost no access to cancer care leading to unnecessary deaths and immeasurable suffering. What is needed is access to the appropriate expertise built from the local community and treatment with effective technology to ensure sustainable capacity and capability. Radiation therapy is an essential component of cancer care, critical for the cure and palliation of over half the patients with cancer. A ready measure for the adequacy of cancer care is access to the radiation therapy machine called the linear accelerator or linac. In addition to its primary goal of education, training and mentoring of cancer care teams in lmics, icec's secondary goal is to improve access to technology for radiation therapy treatment. The scope of the shortage of radiation therapy machines or linacs is staggering. In high-income countries, there is approximately one linac for every 125,000 persons; in some lmics, the ratio is one for every 800,000 -100,000,000. Despite the recognition of this gap decades ago, little…
$126,150 spent$867,489 earned by the program45% of program spendingIcec outreach the need for expertise in global oncology is increasing, with approximately 10.4 million people dying globally from cancer annually. Icec engages in various activities that promote healthcare system strengthening, particularly through workforce capacity and capability-building strategies in low- and middle-income countries worldwide. Icec's outreach program leverages its expansive network of experts, including healthcare professionals, educators, economists and others, to raise awareness and promote substantive involvement in efforts to confront the global cancer crisis. Icec works closely with the research and scientific communities, national and international ngos, governments, regulators, academia, industry, and their regional and international partners in research, presentations at international symposia, and authoring and contributing to a number of peer-reviewed journal articles. In 2024, though the covid-19 pandemic had lessened its grip on the global healthcare community, it further exposed significant inequities within health systems worldwide. Cancer, like covid-19, disproportionately impacts people of color, the impoverished, and historically marginalized…
$100,075 spent$163,290 earned by the program35% of program spendingOther program services, not described on the e-filed return.
$3,461 spentof which $1,000 as grants1% of program spending
The 4 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $282,039.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2023 to 2024, from $1.0M to $2.3M (+125%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2021 2% · 2022 2%. Grants only. Government contracts and fees sit inside program revenue.
99% of INTERNATIONAL CANCER EXPERT CORPS INC’s revenue is contributions — more reliant on donations than three-quarters of its peers (51% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 3 of the last 8 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Chief executive
Eugenia Nina C Wendling
Executive director
Board chair
Surbhi Grover Md Mph
Chair, icec board of directors
As listed on its FY2024 Form 990.
Who funds it, year by year
2017 → 2023: the base broadened from 1 funder to 2 funders, grant income fell $15k → $10k.
4 of 5 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 97% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of INTERNATIONAL CANCER EXPERT CORPS INC’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
INTERNATIONAL CANCER EXPERT CORPS INC leans on a few funders — its largest provides 67% of grant income and the top three 97%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
97% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund INTERNATIONAL CANCER EXPERT CORPS INC.
Largest funder’s share by year: 2017 100% · 2018 100% · 2019 100% · 2020 100% · 2021 100% · 2022 100% · 2023 100% — broadly stable.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
97% of INTERNATIONAL CANCER EXPERT CORPS INC's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $10k that is directly attributable, 100% of it comes from funders outside Washington, D.C., across 1 state.
Funder states come from each funder’s own filing. $290k arriving through sponsors registered in 4 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
INTERNATIONAL CANCER EXPERT CORPS INC runs a healthier operating margin than three-quarters of the 8,121 health nonprofits its size.
this organization peer median middle 50% of peers· 8,121 health nonprofits $1M–$10M, FY2024
Organizations like INTERNATIONAL CANCER EXPERT CORPS INC
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Washington, D.C.
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
75% of spending goes to programs.
Governance
Public support
77%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 1 state
Screen this organization
A dated, signed PDF of the compliance screen for INTERNATIONAL CANCER EXPERT CORPS INC: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds INTERNATIONAL CANCER EXPERT CORPS INC?
- INTERNATIONAL CANCER EXPERT CORPS INC (Washington, D.C.) receives grants from 5 organizations whose IRS filings report $299,552 to it, the largest being MORGAN STANLEY GLOBAL IMPACT FUNDING TRUST INC ($200,000). 3 of them have funded it in more than one year, and 97% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- How many funders does INTERNATIONAL CANCER EXPERT CORPS INC have?
- IRS filings report 5 organizations giving $299,552 in grants to INTERNATIONAL CANCER EXPERT CORPS INC, 3 of which have funded it in more than one year.
- Who is the largest funder of INTERNATIONAL CANCER EXPERT CORPS INC?
- MORGAN STANLEY GLOBAL IMPACT FUNDING TRUST INC is the largest funder on record, with $200,000 in grants. The full list of funders is on this page.
- How can an organization like INTERNATIONAL CANCER EXPERT CORPS INC find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Washington, D.C.. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
Play a game about who funds International Cancer Expert Corps →
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 5 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing